As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/14/22  Allogene Therapeutics, Inc.       SC TO-C                2:34K  Allogene Therapeutics, Inc.                                
 4/14/22  Allogene Therapeutics, Inc.       PRE 14A     6/15/22    1:1.5M                                                            

____________
¹	Filing/Form Types:
	PRE 14A	Preliminary Proxy Statement — Schedule 14A.
	SC TO-C	Tender-Offer Communication by an Issuer or Third Party — Schedule TO.